RxDoctor Payments Data

Hanh Kim

Family · San Diego, CANPI 1568000388

Payments from drug & device makers

$2,878in general payments, 2019–2025

Across 133 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • GSK$547
  • Amgen$276
  • Kowa Pharmaceuticals America, Inc.$247
  • Vanda Pharmaceuticals Inc.$127
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$89
  • plus $498 from 15 others

What the payments were for

  • Food & beverage$2,878100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,878 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol73$57,145
ProliaDenosumab19$31,244
OzempicSemaglutide30$29,963
TradjentaLinagliptin46$29,605
JanuviaSitagliptin Phosphate44$26,206
TrulicityDulaglutide17$22,894
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$22,540
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$16,727
XareltoRivaroxaban12$9,555
JanumetSitagliptin Phos/Metformin Hcl16$8,677
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$8,633
LinzessLinaclotide16$7,875
CreonLipase/Protease/Amylase17$7,412
Semglee (Yfgn) PenInsulin Glargine-Yfgn15$5,034
Fluticasone Propionate294$2,756

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,094$73,871100 claims
AmgenProlia$276$31,24419 claims
Novo NordiskOzempic$16$29,96330 claims
Lilly USA, LLCTrulicity$36$22,89417 claims
GSKTrelegy Ellipta$547$22,54036 claims
AbbVieLinzess, Creon$19$15,28733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.

Other family in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →